Enhanced Expression of Bioactive Recombinant VEGF-111 with Insertion of Intronic Sequence in Mammalian Cell Lines
- 18 February 2015
- journal article
- research article
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 175 (8) , 3737-3749
Abstract
Among all VEGF-A isoforms, VEGF-111 is particularly important in molecular biology research owing to its potent angiogenic properties and its remarkable resistance to proteolysis. These features make it a potential candidate for therapeutic use in ischemic diseases. VEGF-111 is not expressed in normal cells, but expression is induced by UV-B irradiation and exposure to genotoxic agents. Here, to increase expression at the transcriptional and translational levels, we synthesized and cloned recombinant VEGF-111 cDNA. Two fragments encoding exons 1–4 and intron 4/5 plus exon 8a were amplified and cloned into the pBud.CE4.1 vector using a class IIs restriction enzyme-based method. The expression of VEGF-111 in CHO-dhfr − and HEK 293 cell lines was evaluated with real-time PCR, dot blotting, and ELISA. VEGF expression was increased about 10- and 18-fold in transfected CHO-dhfr − and HEK 293 cells, respectively. Dot blotting and ELISA confirmed successful production of VEGF-111 in both cell lines.Keywords
This publication has 23 references indexed in Scilit:
- Why eukaryotic cells use introns to enhance gene expression: Splicing reduces transcription-associated mutagenesis by inhibiting topoisomerase I cutting activityBiology Direct, 2011
- Binding to the Extracellular Matrix and Proteolytic Processing: Two Key Mechanisms Regulating Vascular Endothelial Growth Factor ActionMolecular Biology of the Cell, 2010
- Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cellsJournal of Cell Biology, 2010
- Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic IsoformsJournal of Biological Chemistry, 2010
- VEGF-A splicing: the key to anti-angiogenic therapeutics?Nature Reviews Cancer, 2008
- Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factorsJournal of Cell Science, 2008
- Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agentsJournal of Cell Biology, 2007
- Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibitionCellular Signalling, 2007
- Type II restriction endonucleases: structure and mechanismCellular and Molecular Life Sciences, 2005
- Vascular Endothelial Growth Factor and AngiogenesisPharmacological Reviews, 2004